From: Presentation and outcome of Middle East respiratory syndrome in Saudi intensive care unit patients
 | All patients | Nonsurvivors | Survivors | P value |
---|---|---|---|---|
N | 31 | 23 | 8 | Â |
Age in years (mean ± SD) | 59 ± 20 | 63 ± 19 | 46 ± 20 | 0.048 |
Male, n (%) | 22 (71.0) | 15 (65.2) | 7 (87.3) | 0.379 |
Body mass index in kg/m2 (mean ± SD) | 29.8 ± 7.6 | 29.3 ± 7.1 | 31.2 ± 9.2 | 0.707 |
Severity scores (mean ± SD) | ||||
 APACHE II score | 24.2 ± 9.5 | 26.4 ± 8.5 | 17.8 ± 9.7 | 0.034 |
 SOFA score | 10.7 ± 3.5 | 11.7 ± 3.1 | 8.0 ± 3.2 | 0.01 |
Acquisition of pneumonia, n (%) | Â | Â | Â | 0.689 |
 Community-acquired | 18 (58.1) | 14 (60.9) | 4 (50.0) |  |
 Hospital-acquired | 13 (41.9) | 9 (39.1) | 4 (50.0) |  |
Comorbidities, n (%) | ||||
 Diabetes mellitus | 17 (54.8) | 13 (56.5) | 4 (50.0) | 1.00 |
 Arterial hypertension | 16 (51.6) | 14 (60.9) | 2 (25.0) | 0.113 |
 Immunosuppressive drugs | 7 (22.6) | 5 (21.7) | 2 (25.0) | 1.00 |
 Chronic heart failure | 6 (19.4) | 4 (17.4) | 2 (25.0) | 1.00 |
 Chronic kidney disease | 6 (19.4) | 4 (17.4) | 2 (25.0) | 0.634 |
 Cerebrovascular accidents | 5 (16.1) | 4 (17.4) | 1 (12.5) | 1.00 |
 Coronary artery disease | 4 (12.9) | 3 (13.0) | 0 (0.0) | 1.00 |
 Steroid use | 3 (9.6) | 3 (13.0) | 0 (0.0) | 0.161 |
 COPD | 3 (9.7) | 2 (8.7) | 1 (12.5) | 1.00 |
 Smoking | 3 (9.7) | 1 (4.3) | 2 (25.0) | 0.156 |
 Chronic liver disease | 3 (9.7) | 3 (13.0) | 0 (0.0) | 0.550 |
 Hypothyroid | 3 (9.7) | 3 (13.0) | 0 (0.0) | 0.550 |
 Cancer | 2 (6.5) | 2 (8.7) | 0 (0.0) | 1.00 |
 Epilepsy | 2 (6.5) | 1 (4.3) | 1 (12.5) | 0.456 |
 Dyslipidemia | 1 (3.2) | 1 (4.3) | 0 (0.0) | 1.00 |
 Asthma | 1 (3.2) | 1 (4.3) | 0 (0.0) | 1.00 |
 Bronchiectasis | 1 (3.2) | 1 (4.3) | 0 (0.0) | 1.00 |
 Obstructive sleep apnea | 1 (3.2) | 1 (4.3) | 0 (0.0) | 1.00 |
Number of comorbidities, median (IQR) | 3 (2–4) | 3 (2–4) | 3 (1–4) | 0.580 |
ICU mortality, n (%) | 23 (74.2) | 23 (100) | - | NA |
ICU length of stay in days [median, (IQR)] | 9 (4–16) | 10 (4–16) | 9 (4–17) | 0.912 |
Hospital length of stay in days [median, (IQR)] | 12 (4–16) | 10 (4–16) | 18 (14–72) | 0.002 |